Monthly Archives: April 2008

USFDA clears Yulex Corp.’s glove made from new type of Latex

April 30th, 2008|

The U.S. Food and Drug Administration has cleared for marketing the first device made from a new form of natural rubber latex, guayule latex. The product, the Yulex Patient Examination Glove, is derived from the guayule bush, a desert plant native to the Southwestern United States.

US FDA approves Cimzia to Treat Crohn’s Disease

April 30th, 2008|

The U.S. Food and Drug Administration has approved Cimzia (certolizumab pegol) with a Medication Guide, for adults with moderate to severe Crohn's disease who have not responded to conventional therapies.

Avesthagen signs agreement with ShigaMediX to develop cervical cancer and TB vaccines

April 30th, 2008|

Avesthagen has signed a letter of intent with Paris-based ShigaMediX SAS for developing a novel therapeutic vaccine against HPV (Human Papilloma Virus), which causes cervical cancer.

Transasia receives first Maharashtra export award

April 29th, 2008|

Transasia, first Indian company to received the First State level Export award & the Second Regional award by The Industries Department, Government  of Maharashtra, an western state of India in recognition of the export performance for the year 2006-07 and 2005-06 respectively.

Relistor gets USFA approval

April 29th, 2008|

Progenics Pharmaceuticals, Inc. and Wyeth Pharmaceuticals has received  US Food and Drug Administration (FDA) approval for  Relistor (methylnaltrexone bromide) subcutaneous injection for the treatment of opioid-induced constipation (OIC) in patients with advanced illness who are receiving palliative care

Teva gets tentative approval for generic Evista

April 29th, 2008|

Teva Pharmaceutical Industries Ltd has received US Food and Drug Administration approval for Abbreviated New Drug Application (ANDA) to market its generic version of Lilly's osteoporosis treatment Evista (Raloxifene Hydrochloride) Tablets, 60 mg.

Ranbaxy gets USFDA approval to market Cetirizine in US

April 29th, 2008|

Ranbaxy Laboratories has received final approval from the US Food and Drug Administration to manufacture and market Cetirizine Hydrochloride Oral Solution (Allergy) and Children’s Cetirizine Hydrochloride Oral Solution (Hives-Relief), 1 mg/mL (OTC).

“India represents a global genetic mosaic in its population, said Sibal, Minister for Science and Te

April 29th, 2008|

India unveiled the genetic map of its citizens. In one of the most startling revelations, the study said most Indians—Aryans of the North and Dravidians of the south-are genetically related.

“Conservation of genetic diversity must for sustainable agriculture in India” – Mr Sharad Pawar, Min

April 29th, 2008|

For sustainable development of agriculture, the Government of India is looking at proper management of plant and animal genetic resources. The government has taken a number of steps to conserve India’s rich genetic diversity and many more are in the offing

Prices of 1421 drugs fixed for the first time in 2007-08

April 28th, 2008|

Minister of State for Chemicals & Fertilizers Shri B.K. Handique informed that the 74 bulk drugs specified in the First Schedule of the Drugs (Prices Control) Order, 1995 (DPCO,95) and the formulations based thereon are under price control and their prices are fixed/revised by the National Pharmaceutical Pricing Authority (NPPA) in accordance with the provisions of the DPCO, 95.  Such prices are applicable to manufacturers concerned throughout the country unless otherwise exempted under the provisions of DPCO 95.

Achievements of NRHM Schemes in North Eastern Region

April 27th, 2008|

Minister of State for Health & Family Welfare, Smt. Panabaaka Lakshmi informed that National Rural Health Mission (NRHM) Ministry of Health & Family Welfare programme i.e was launched by Hon’ble Prime Minister on 12th April 2005. The NRHM provides the overarching umbrella to the existing programmes of Health and Family Welfare including Reproductive Child Health Programme-II, National Vector Borne Disease Control Programme, National Blindness Control Programme, National Iodine deficiency Control Programme, Revised National TB Control Programme, National Leprosy Eradication Programme and Integrated Disease Surveillance Programme.

Biovet plans to launch Asia’s first BSL-4 production plant for FMD vaccine

April 25th, 2008|

Biovet, an integrated animal health company, has invested Rs 1.8 crore to open Asia's first bio-safety level 4 BSL-4 production plant at the Malur in the outskirts of Bangalore for manufacture of Food & Mouth Disease (FMD) vaccine for the first time in the country by the private sector.

Scarcity of medical infrastructure and doctors in rural India

April 25th, 2008|

The Minister of State for Health & Family Welfare, Smt. Panabaaka Lakshmi informed that in  rural areas, primary health care services are being provided through a network of 145272 Sub-centres (SCs), 22370 Primary Health Centres (PHCs) and 4045 Community Health Centres (CHCs) as on March 2007.

CordLife opens cord blood facility in India

April 25th, 2008|

CordLife has opened its operation in Kolkata, India with state- of- the- art cord blood tissue processing and storage facility. The facility received an official license from the central and state drug regulatory authorities, a department within the Ministry of Health and Family Welfare of India.

Centre hikes assistance to 30 % for ASU units to meet GMP norms

April 25th, 2008|

The Central government has raised the financial assistance from the existing 20% to 30% to the Ayurveda, Siddha and Unani drug manufacturing units for upgrading their infrastructure to meet GMP norms, during the 11th Five Year Plan period.

Biotech companies should focus on developing end-products – Prof. Sidney Altman

April 25th, 2008|

Biotech companies in the South East Asian countries must focus more on producing their own end products for domestic markets as well as exports, said Prof. Sidney Altman, Nobel Laureate and Sterling Professor of Molecular, Cellular and Developmental Biology, Yale University, USA

Anu’s Labs to setup an API facility in Andhra Pradesh

April 25th, 2008|

Anu's Laboratories Ltd is setting up a new manufacturing facility for active pharmaceutical ingredients (API) at  Vishakhapattnam in Andhra Pradesh by investing close to Rs 65 crore. The construction work for the new facility is on stream and the new facility is likely to be commissioned by the end of current financial year.

$10 bn Biogenerics Market up for Grabs

April 25th, 2008|

Biotechnology is one of the sunrise sectors of the Indian economy. The industry includes firms that use cells and biological molecules for applications in medicine (both veterinary and human medicine)…[English]-[French]-[Spanish]

Cliniminds to set up centres at Ahmedabad, Hyderabad and Mumbai

April 25th, 2008|

Cliniminds, is expanding its business activity across India with an initial investment of Rs 60 lakh. It is setting up its training centres as well online distance learning programme at Ahmedabad, Hyderabad and Mumbai. The management is planning all centres by the end of 2008.

Health ministry to convert vaccine institutes into testing & training labs

April 25th, 2008|

The Union ministry of health has decided to convert the three vaccines and sera manufacturing units in the public sector, whose production licenses were suspended in January 2008, of CRI, Kasuli, PII, Coonoor and BCG Vaccine Lab, into testing and training laboratories.